Cryo Cell International (CCEL) Accounts Payables (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Accounts Payables data on file, last reported at $3.3 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $3.3 million, up 20.3% year-over-year; the trailing twelve-month figure through Feb 2026 was $3.3 million (up 20.3% YoY), and the FY2025 annual result was $2.9 million, up 52.52% from the prior year.
• Accounts Payables rose to $3.3 million in Q1 2026 per CCEL's latest filing, from $2.9 million in the prior quarter.
• Over five years, Accounts Payables peaked at $4.1 million in Q2 2023 and troughed at $491920.0 in Q4 2023.
• A 5-year average of $2.3 million and a median of $2.2 million in 2025 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables tumbled 69.36% in 2023, then soared 282.64% in 2024.
• A 5-year view of Accounts Payables shows it stood at $1.6 million in 2022, then plunged by 69.36% to $491920.0 in 2023, then soared by 282.64% to $1.9 million in 2024, then surged by 52.52% to $2.9 million in 2025, then increased by 15.0% to $3.3 million in 2026.
• Business Quant data shows CCEL's Accounts Payables at $3.3 million in Q1 2026, $2.9 million in Q4 2025, and $2.6 million in Q3 2025.